Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-9,563
Closed -$717K 1091
2022
Q1
$717K Buy
+9,563
New +$732K ﹤0.01% 1008
2021
Q2
Sell
-13,779
Closed -$1.23M 936
2021
Q1
$1.23M Sell
13,779
-4,578
-25% -$374K 0.01% 807
2020
Q4
$1.34M Sell
18,357
-14,881
-45% -$1.06M 0.01% 805
2020
Q3
$2.27M Buy
33,238
+1,138
+4% +$83.7K 0.01% 706
2020
Q2
$2.26M Sell
32,100
-32,406
-50% -$2.18M 0.01% 737
2020
Q1
$3.75M Buy
64,506
+39,285
+156% +$2.67M 0.03% 509
2019
Q4
$1.88M Buy
+25,221
New +$1.9M 0.01% 790

Other funds holding MMS

Aviva's MMS Position: Q2 2022 in Review

Aviva sold out of Maximus (MMS) in Q2 2022, closing a stake of 9,563 shares — an estimated $717K sold.

Aviva first reported a position in MMS in Q4 2019 and held it in 7 quarters. The position peaked at $3.75M in Q1 2020. 308 funds tracked by Wall St. Rank hold MMS as of Q2 2022.

  • Aviva reported no remaining Maximus position as of Q2 2022 after selling out during the quarter.
  • Aviva sold 9,563 Maximus shares in Q2 2022, an estimated $717K.
  • Aviva first reported a position in Maximus in Q4 2019 and held it in 7 quarters.
  • Aviva's Maximus position peaked at $3.75M in Q1 2020.
  • 308 funds tracked by Wall St. Rank held Maximus as of Q2 2022.

Based on Aviva's 13F filing for Q2 2022, filed 4 Aug 2022.